Upsher-Smith expands Vigadrone product line

Upsher-Smith is offering Vigadrone (vigabatrin) tablets, 500 mg,  the generic of Lundbeck’s Sabril. The product is available in 100-count bottles.

The company also offers Vigadrone (vigabatrin) for Oral Solution, 500 mg.

“Upsher-Smith is always looking for innovative and impactful ways to make prescribing our products easier for physicians and more accessible to patients,” said Rich Fisher, president and chief operating officer at Upsher-Smith. “We understand the challenges associated with prescribing and accessing specialty drugs, particularly vigabatrin, and our team is committed to providing service and support that helps give peace of mind to our providers and patients.”

[Read more: Upsher-Smith opens manufacturing facility in Minnesota]

Vigadrone is indicated for the treatment of: Infantile Spasms in patients 1 month to 2 years of age, if you and your healthcare provider decide the possible benefits of taking Vigadrone are more important than the possible risk of vision loss; Refractory Complex Partial Seizures in adults and children 2 years and older with refractory complex partial seizures along with other treatments if: the CPS do not respond well enough to several other treatments, and you and your healthcare provider decide the possible benefit of taking Vigadrone is more important than the risk of vision loss.

[Read more: Upsher-Smith extends fluoxetine product line]

Vigadrone should not be the first medicine used to treat CPS.